Cited by 655Cardiac electrophysiology and arrhythmiasIon channel regulation and functionCardiovascular Effects of Exercise

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Open access

Lahat, Hadas, Pras, Elon, Olender, Tsviya, Avidan, Nili, Ben-Asher, Edna, Man, Orna, Levy-Nissenbaum, Etgar, Khoury, Asad, Lorber, Avraham, Goldman, Boleslaw, Lancet, Doron, Eldar, Michael·2001·The American Journal of Human Genetics

DOI 10.1086/324565PMC PMC1235548

Open this paper in CoChat — free account

Abstract

Catecholamine-induced polymorphic ventricular tachycardia (PVT) is characterized by episodes of syncope, seizures, or sudden death, in response to physical activity or emotional stress. Two modes of inheritance have been described: autosomal dominant and autosomal recessive. Mutations in the ryanodine receptor 2 gene (RYR2), which encodes a cardiac sarcoplasmic reticulum (SR) Ca(2+)-release channel, were recently shown to cause the autosomal dominant form of the disease. In the present report, we describe a missense mutation in a highly conserved region of the calsequestrin 2 gene (CASQ2) as the potential cause of the autosomal recessive form. The CASQ2 protein serves as the major Ca(2+) reservoir within the SR of cardiac myocytes and is part of a protein complex that contains the ryanodine receptor. The mutation, which is in full segregation in seven Bedouin families affected by the disorder, converts a negatively charged aspartic acid into a positively charged histidine, in a highly negatively charged domain, and is likely to exert its deleterious effect by disrupting Ca(2+) binding.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1086/324565

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Cardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,380
INTRACELLULAR CALCIUM HOMEOSTASIS
Carafoli, E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002143 · Cited by 2,189
[22] Using CLUSTAL for multiple sequence alignments
Higgins, D. G., Thompson, J., & Gibson, T. J. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)66024-8 · Cited by 1,571
Mutations in the Cardiac Ryanodine Receptor Gene ( hRyR2 ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia
Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V., & Danieli, G. A. (2001) · Circulation · doi:10.1161/01.cir.103.2.196 · Cited by 1,378
Cardiac Electrophysiology: From Cell to Bedside
Kuo, P. T. (1995) · JAMA · doi:10.1001/jama.1995.03530060083043 · Cited by 1,140
Catecholaminergic Polymorphic Ventricular Tachycardia in Children
Leenhardt, A., Lucet, V., Denjoy, I., Grau, F., Ngoc, D. D., & Coumel, P. (1995) · Circulation · doi:10.1161/01.cir.91.5.1512 · Cited by 994
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
Tiso, N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.189 · Cited by 813
Catecholamine cardiotoxicity
Róna, G. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(85)80130-9 · Cited by 726
Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia
Laitinen, P. J., Brown, K. M., Piippo, K., Swan, H., Devaney, J. M., Brahmbhatt, B., Donarum, E. A., Marino, M., Tiso, N., Viitasalo, M., et al. (2001) · Circulation · doi:10.1161/01.cir.103.4.485 · Cited by 726

Show all 25 references

Sorted by citations

Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Priori, S. G., Wilde, A. A., Horie, M., Cho, Y., Behr, E. R., Berul, C., Blom, N., Brugada, J., Chiang, C.-E., Huikuri, H., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.05.014 · Cited by 1,942
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C. I., Brugada, R., Calkins, H. G., Camm, A. J., Ellinor, P. T., Gollob, M. H., Hamilton, R. M., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,472
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C. I., Brugada, R., Calkins, H. G., Camm, A. J., Ellinor, P. T., Gollob, M. H., Hamilton, R. M., et al. (2011) · EP Europace · doi:10.1093/europace/eur245 · Cited by 881
Ryanodine Receptors: Structure, Expression, Molecular Details, and Function in Calcium ReleasePreprint
Lanner, J. T., Georgiou, D. K., Joshi, A., & Hamilton, S. L. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003996 · Cited by 814
Multi-ethnic genome-wide association study for atrial fibrillation
Roselli, C., Chaffin, M. D., Weng, L.-C. C., Aeschbacher, S., Ahlberg, G., Albert, C. M., Almgren, P., Alonso, Á., Anderson, C. D., Aragam, K. G., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0133-9 · Cited by 761
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 741
The Human Gene Map for Performance and Health-Related Fitness Phenotypes
Rankinen, T., Bray, M. S., Hagberg, J. M., Përusse, L., Roth, S. M., Wolfarth, B., & Bouchard, C. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233789.01164.4f · Cited by 734
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes
Priori, S. G., Wilde, A. A. M., Horie, M., Cho, Y., Behr, E. R., Berul, C. I., Blom, N. A., Brugada, J., Chiang, C., Huikuri, H. V., et al. (2013) · EP Europace · doi:10.1093/europace/eut272 · Cited by 626
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Watanabe, H., Chopra, N., Laver, D. R., Hwang, H. S., Davies, S. S., Roach, D. E., Duff, H. J., Roden, D. M., Wilde, A. A. M., & Knollmann, B. C. (2009) · Nature Medicine · doi:10.1038/nm.1942 · Cited by 605
Calcium Signaling and Cardiac Arrhythmias
Landstrom, A. P., Dobrev, D., & Wehrens, X. H. T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310083 · Cited by 596
Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia
Hayashi, M., Denjoy, I., Extramiana, F., Maltret, A., Buisson, N. R., Lupoglazoff, J.-M., Klug, D., Hayashi, M., Takatsuki, S., Villain, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.829267 · Cited by 555
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
The Human Gene Map for Performance and Health-Related Fitness Phenotypes
Bray, M. S., Hagberg, J. M., Përusse, L., Rankinen, T., Roth, S. M., Wolfarth, B., & Bouchard, C. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181844179 · Cited by 477
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia
Knollmann, B. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29128 · Cited by 445
Inherited Dysfunction of Sarcoplasmic Reticulum Ca 2+ Handling and Arrhythmogenesis
Priori, S. G., & Chen, S. R. W. (2011) · Circulation Research · doi:10.1161/circresaha.110.226845 · Cited by 442
RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca 2+ release (SOICR)
Jiang, D., Xiao, B., Yang, D., Wang, R., Choi, P. M. C., Zhang, L., Cheng, H., & Chen, S. R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402388101 · Cited by 441
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 463
Genome-wide Orchestration of Cardiac Functions by the Orphan Nuclear Receptors ERRα and γ
Dufour, C. R., Wilson, B. J., Huss, J. M., Kelly, D. P., Alaynick, W. A., Downes, M., Evans, R. M., Blanchette, M., & Giguère, V. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.007 · Cited by 431
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
Behr, E. R., Dalageorgou, C., Christiansen, M., Syrris, P., Hughes, S., Tome, M., Rowland, E., Jeffery, S., & McKenna, W. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn219 · Cited by 417
Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice
Lehnart, S. E., Mongillo, M., Bellinger, A. M., Lindegger, N., Chen, B.-X., HSUEH, W. H., Reiken, S. R., Wronska, A., Drew, L., Ward, C. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35346 · Cited by 413
Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia
Postma, A. V., Denjoy, I., Hoorntje, T. M., Lupoglazoff, J., Costa, A. D., Sébillon, P., Mannens, M. M. A. M., Wilde, A. A. M., & Guicheney, P. (2002) · Circulation Research · doi:10.1161/01.res.0000038886.18992.6b · Cited by 409
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000498 · Cited by 411
Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
van der Werf, C., Kannankeril, P. J., Sacher, F., Krahn, A. D., Viskin, S., Leenhardt, A., Shimizu, W., Sumitomo, N., Fish, F. A., Bhuiyan, Z. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.026 · Cited by 406
Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death
Nyegaard, M., Overgaard, M. T., Søndergaard, M. T., Vranas, M., Behr, E. R., Hildebrandt, L. L., Lund, J., Hedley, P. L., Camm, A. J., Wettrell, G., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.015 · Cited by 403
Cardiac Innervation and Sudden Cardiac Death
Fukuda, K., Kanazawa, H., Aizawa, Y., Ardell, J. L., & Shivkumar, K. (2015) · Circulation Research · doi:10.1161/circresaha.116.304679 · Cited by 403
Modulation of the Ryanodine Receptor and Intracellular Calcium
Zalk, R., Lehnart, S. E., & Marks, A. R. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.053105.094237 · Cited by 371
Enhanced Store Overload–Induced Ca 2+ Release and Channel Sensitivity to Luminal Ca 2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death
Jiang, D., Wang, R., Xiao, B., Kong, H., Hunt, D. J., Choi, P. M. C., Zhang, L., & Chen, S. R. W. (2005) · Circulation Research · doi:10.1161/01.res.0000192146.85173.4b · Cited by 359
Calcium and Arrhythmogenesis
ter Keurs, H. E. D. J., & Boyden, P. A. (2007) · Physiological Reviews · doi:10.1152/physrev.00011.2006 · Cited by 353
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.003 · Cited by 327
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients
Postma, A. V., Denjoy, I., Kamblock, J., Alders, M. M., Lupoglazoff, J., Vaksmann, G., Duboscq-Bidot, L., Sébillon, P., Mannens, M. M. A. M., Guicheney, P., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028993 · Cited by 304
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia
Ferrari, G. M. D., Dusi, V., Spazzolini, C., Bos, J. M., Abrams, D. J., Berul, C. I., Crotti, L., Davis, A. M., Eldar, M., Kharlap, M. S., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015731 · Cited by 303
Self-citation
Calsequestrin and the calcium release channel of skeletal and cardiac muscle
Beard, N. A., Laver, D. R., & Dulhunty, A. F. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.07.001 · Cited by 292
Genetics of Sudden Cardiac Death
Bezzina, C. R., Lahrouchi, N., & Priori, S. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.304030 · Cited by 292
Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes
Choi, G. R., Kopplin, L. J., Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000144471.98080.ca · Cited by 271
Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Priori, S. G., Wilde, A. A. M., Horie, M., Cho, Y., Behr, E. R., Berul, C. I., Blom, N. A., Brugada, J., Chiang, C., Huikuri, H. V., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.021 · Cited by 272
The human protein disulfide isomerase gene family
Galligan, J. J., & Petersen, D. R. (2012) · Human Genomics · doi:10.1186/1479-7364-6-6 · Cited by 270
Genetic causes of human heart failure
Morita, H., Seidman, J. G., & Seidman, C. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24351 · Cited by 264
KCNJ2 Mutation Results in Andersen Syndrome with Sex-Specific Cardiac and Skeletal Muscle Phenotypes
Andelfinger, G., Tapper, A. R., Welch, R. C., Vanoye, C. G., George, A. L., & Benson, D. W. (2002) · The American Journal of Human Genetics · doi:10.1086/342360 · Cited by 259
Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia
Terentyev, D. A., Viatchenko‐Karpinski, S., Györke, I., Pompeo Volpe, D., Williams, S. C., & Györke, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932318100 · Cited by 257
Ryanodine Receptor Mutations Associated With Stress-Induced Ventricular Tachycardia Mediate Increased Calcium Release in Stimulated Cardiomyocytes
George, C. H., Higgs, G. V., & Lai, F. A. (2003) · Circulation Research · doi:10.1161/01.res.0000091335.07574.86 · Cited by 256
Inherited Arrhythmias
Lehnart, S. E., Ackerman, M. J., Benson, D. W., Brugada, R., Clancy, C. E., Donahue, J. K., George, A. L., Grant, A. O., Groft, S. C., January, C. T., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.711689 · Cited by 253
Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease
Györke, S., & Terentyev, D. A. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm038 · Cited by 252
Expanding Spectrum of Human RYR2 -Related Disease
Bhuiyan, Z. A., van den Berg, M. P., van Tintelen, J. P., Bink‐Boelkens, M. T. E., Wiesfeld, A. C. P., Alders, M. M., Postma, A. V., van Langen, I. M., Mannens, M. M. A. M., & Wilde, A. A. M. (2007) · Circulation · doi:10.1161/circulationaha.107.711606 · Cited by 248
Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease
Stutzmann, G. E., & Mattson, M. P. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003814 · Cited by 255
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Priori, S. G., Wilde, A. A. M., Horie, M., Cho, Y., Behr, E. R., Berul, C. I., Blom, N. A., Brugada, J., Chiang, C., Huikuri, H. V., et al. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.07.002 · Cited by 244
Calcium-release channels: structure and function of IP3 receptors and ryanodine receptors
Woll, K. A., & Petegem, F. V. (2021) · Physiological Reviews · doi:10.1152/physrev.00033.2020 · Cited by 235
The sarcoplasmic reticulum and arrhythmogenic calcium release
Venetucci, L. A., Trafford, A. W., O'Neill, S. C., & Eisner, D. A. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm009 · Cited by 229
Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells
Itzhaki, I., Maizels, L., Huber, I., Gepstein, A., Arbel, G., Caspi, O., Miller, L., Belhassen, B., Nof, E., Glikson, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.066 · Cited by 228
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications
Goldfracht, I., Efraim, Y., Shinnawi, R., Kovalev, E., Huber, I., Gepstein, A., Arbel, G., Shaheen, N., Tiburcy, M., Zimmermann, W. H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.016 · Cited by 222
Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia
di Barletta, M. R., Viatchenko‐Karpinski, S., Nori, A., Memmi, M., Terentyev, D. A., Turcato, F., Valle, G., Rizzi, N., Napolitano, C., Györke, S., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.623793 · Cited by 206
Catecholaminergic Polymorphic Ventricular Tachycardia
Liu, N., Ruan, Y., & Priori, S. G. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.10.005 · Cited by 204
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death
Terentyev, D. A., Nori, A., Santoro, M., Viatchenko‐Karpinski, S., Kubalová, Z., Györke, I., Terentyeva, R., Vedamoorthyrao, S., Blom, N. A., Valle, G., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000220647.93982.08 · Cited by 195
In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells
Fatima, A., Xu, G., Shao, K., Papadopoulos, S., Lehmann, M., Arnáiz‐Cot, J. J., Rosa, A. O., Nguemo, F., Matzkies, M., Dittmann, S., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335753 · Cited by 204
Molecular Basis of Arrhythmias
Shah, M. H., Akar, F. G., & Tomaselli, G. F. (2005) · Circulation · doi:10.1161/circulationaha.104.494476 · Cited by 191
Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes
Giudicessi, J. R., & Ackerman, M. J. (2012) · Translational research · doi:10.1016/j.trsl.2012.08.005 · Cited by 191
Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia
Song, L., Alcalai, R., Arad, M., Wolf, C. M., Toka, O., Conner, D. A., Berul, C. I., Eldar, M., Seidman, C. E., & Seidman, J. G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31080 · Cited by 187
Self-citation
Inherited calcium channelopathies in the pathophysiology of arrhythmias
Venetucci, L. A., Denegri, M., Napolitano, C., & Priori, S. G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.93 · Cited by 187
Ion Channels in the Heart
Bartos, D. C., Grandi, E., & Ripplinger, C. M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140069 · Cited by 215
Genetic testing for inherited cardiac disease
Wilde, A. A. M., & Behr, E. R. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.108 · Cited by 182
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β‐adrenergic stimulation
Novak, A., Barad, L., Zeevi‐Levin, N., Shick, R., Shtrichman, R., Lorber, A., Itskovitz‐Eldor, J., & Binah, O. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01476.x · Cited by 182
Self-citation
Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy
Kho, C., Lee, A., & Hajjar, R. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.145 · Cited by 177
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia
Rosso, R., Kalman, J. M., Rogowski, O., Diamant, S., Birger, A., Biner, S., Belhassen, B., & Viskin, S. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.05.017 · Cited by 176
Catecholaminergic Polymorphic Ventricular Tachycardia
Leenhardt, A., Denjoy, I., & Guicheney, P. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962027 · Cited by 174
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
Kannankeril, P. J., Moore, J. P., Cerrone, M., Priori, S. G., Kertesz, N. J., Ro, P. S., Batra, A. S., Kaufman, E. S., Fairbrother, D. L., Saarel, E. V., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1320 · Cited by 173
Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin
Viatchenko‐Karpinski, S., Terentyev, D. A., Györke, I., Terentyeva, R., Pompeo Volpe, D., Priori, S. G., Napolitano, C., Nori, A., Williams, S. C., & Györke, S. (2004) · Circulation Research · doi:10.1161/01.res.0000115944.10681.eb · Cited by 171
Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects
Skinner, J. R., Winbo, A., Abrams, D. J., Vohra, J. K., & Wilde, A. A. M. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.007 · Cited by 170
Ryanodine Receptors: Allosteric Ion Channel Giants
Petegem, F. V. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.08.004 · Cited by 161
Epidemiology of Arrhythmias and Sudden Cardiac Death in Asia
Murakoshi, N., & Aonuma, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1129 · Cited by 167
Ryanodine receptors and ventricular arrhythmias: Emerging trends in mutations, mechanisms and therapies
George, C. H., Jundi, H., Thomas, N. L., Fry, D. L., & Lai, F. A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.115 · Cited by 163
Inhibition of Cardiac Ca 2+ Release Channels (RyR2) Determines Efficacy of Class I Antiarrhythmic Drugs in Catecholaminergic Polymorphic Ventricular Tachycardia
Hwang, H. S., Hasdemir, C., Laver, D. R., Mehra, D., Turhan, K., Faggioni, M., Yin, H., & Knollmann, B. C. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.959916 · Cited by 158
Sudden Cardiac Death and Genetic Ion Channelopathies
Napolitano, C., Bloise, R., Monteforte, N., & Priori, S. G. (2012) · Circulation · doi:10.1161/circulationaha.111.055947 · Cited by 152
Increased Ca 2+ Sensitivity of the Ryanodine Receptor Mutant RyR2 R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia
Fernández‐Velasco, M., Rueda, A., Rizzi, N., Bénitah, J., Colombi, B., Napolitano, C., Priori, S. G., Richard, S., & Gomez, A. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.177493 · Cited by 151
Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptation
Yu, L., Wang, G., Ruan, J., Chen, Y.-B., Yang, C.-P., Cao, X., Wu, H., Yan-hu, L., Du, Z.-L., Wang, X.-P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3615 · Cited by 153
Comparing Skeletal and Cardiac Calsequestrin Structures and Their Calcium Binding
Park, H., Park, I. Y., Kim, E., Youn, B., Fields, K., Dunker, A. K., & Kang, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311553200 · Cited by 150
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper.
Gollob, M., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., Gardner, M., Green, M., Gow, R., Hamilton, R., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.078 · Cited by 157
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia
Napolitano, C., & Priori, S. G. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2006.12.048 · Cited by 148
Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances
Fernández-Falgueras, A., Sarquella‐Brugada, G., Brugada, J., Brugada, R., & Campuzano, Ó. (2017) · Biology · doi:10.3390/biology6010007 · Cited by 146
Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death
Behr, E. R., Casey, A., Sheppard, M. N., Wright, M., Bowker, T. J., Davies, M. J., McKenna, W. J., & Wood, D. A. (2007) · Heart · doi:10.1136/hrt.2006.099598 · Cited by 139
Unexpected Structural and Functional Consequences of the R33Q Homozygous Mutation in Cardiac Calsequestrin
Rizzi, N., Liu, N., Napolitano, C., Nori, A., Turcato, F., Colombi, B., Bicciato, S., Arcelli, D., Spedito, A., Scelsi, M., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.171660 · Cited by 138
TECRL, a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT
Devalla, H. D., Gélinas, R., Aburawi, E. H., Beqqali, A., Goyette, P., Freund, C. M. A. H., Chaix, M., Tadros, R., Jiang, H., Béchec, A. L., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505719 · Cited by 137
Ryanodine receptor channelopathies
Betzenhauser, M. J., & Marks, A. R. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0794-4 · Cited by 136
Association of Atrial Arrhythmia and Sinus Node Dysfunction in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
Sumitomo, N., Sakurada, H., Taniguchi, K., Matsumura, M., Abe, O., Miyashita, M., Kanamaru, H., Karasawa, K., Ayusawa, M., Fukamizu, S., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.1606 · Cited by 134
Luminal Ca2+ Regulation of Single Cardiac Ryanodine Receptors: Insights Provided by Calsequestrin and its Mutants
Qin, J., Valle, G., Nani, A., Nori, A., Rizzi, N., Priori, S. G., Pompeo Volpe, D., & Fill, M. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200709907 · Cited by 133
Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters
Shinnawi, R., Huber, I., Maizels, L., Shaheen, N., Gepstein, A., Arbel, G., Tijsen, A. J., & Gepstein, L. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.009 · Cited by 131
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia
Rosés‐Noguer, F., Jarman, J. W. E., Clague, J. R., & Till, J. A. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.027 · Cited by 128
Genetics of sudden death: focus on inherited channelopathies.
Cerrone, M., & Priori, S. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr082 · Cited by 128
Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle
Györke, S. (2002) · Frontiers in bioscience · doi:10.2741/a852 · Cited by 127
Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1
Glukhov, A. V., Kalyanasundaram, A., Lou, Q., Hage, L. T., Hansen, B. J., Belevych, A. E., Mohler, P. J., Knollmann, B. C., Periasamy, M., Györke, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht452 · Cited by 126
Role of Sodium and Calcium Dysregulation in Tachyarrhythmias in Sudden Cardiac Death
Wagner, S., Maier, L. S., & Bers, D. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.304678 · Cited by 132
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
Yamaguchi, N., Takahashi, N., Xu, L., Smithies, O., & Meissner, G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29515 · Cited by 126
Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia
Wleklinski, M. J., Kannankeril, P. J., & Knollmann, B. C. (2020) · The Journal of Physiology · doi:10.1113/jp276757 · Cited by 125
Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations
Shastry, S., Delgado, M. R., Dırık, E., Turkmen, M. A., Agarwal, A. K., & Garg, A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33578 · Cited by 122
The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry
Roston, T. M., Yuchi, Z., Kannankeril, P. J., Hathaway, J., Vinocur, J. M., Etheridge, S. P., Potts, J. E., Maginot, K. R., Salerno, J. C., Cohen, M. I., et al. (2016) · EP Europace · doi:10.1093/europace/euw389 · Cited by 122
The Human Gene Map for Performance and Health-Related Fitness Phenotypes: The 2002 Update
Përusse, L., Rankinen, T., Rauramaa, R., Rivera, M. A., Wolfarth, B., & Bouchard, C. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078938.84161.22 · Cited by 121
Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia
Mohamed, U., Gollob, M. H., Gow, R. M., & Krahn, A. D. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.08.018 · Cited by 121

Authors: Lahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., Lancet, D., & Eldar, M.
Affiliations: Sheba Medical Center (IL)
Crown Human Genome Center (IL)
Rambam Health Care Campus (IL)
Corresponding author: Pras, Elon
ORCID: Pras, Elon
Olender, Tsviya
Avidan, Nili
Lorber, Avraham
Goldman, Boleslaw
Lancet, Doron
Venue: The American Journal of Human Genetics
Publisher: Elsevier BV
Published: 2001-12
Volume: 69
Issue: 6
Pages: 1378-1384
ISSN: 0002-9297 (ISSN-L)
DOI: 10.1086/324565
PMC: PMC1235548
OpenAlex: W2090820454
Cited by: 655
References: 25
Citations by year: 2026: 9 · 2025: 12 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 20 · 2020: 36 · 2019: 22 · 2018: 14 · 2017: 37 · 2016: 33 · 2015: 29 · 2014: 23 · 2013: 45 · 2012: 48
FWCI: 14.21
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4248 d)
Locations: The American Journal of Human Genetics (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Israel Science Foundation
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: CASQ2, missense mutations, autosomal recessive inheritance, RyR2, cardiac sarcoplasmic reticulum, calcium binding, Bedouin family, sudden cardiac death, syncope
MeSH terms: Amino Acid Sequence, Base Sequence, Calsequestrin, Catecholamines, Child, DNA Mutational Analysis, Electrocardiography, Ethnicity, Exons, Female, Genes, Recessive, Humans, Israel, Male, Models, Molecular, Molecular Sequence Data, Pedigree, Protein Conformation, Sequence Alignment, Conserved Sequence, Tachycardia, Ventricular, Age of Onset, Mutation, Missense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks